Does a positive pretransplant crossmatch affect long-term outcome in liver transplantation?

Hdl Handle:
http://hdl.handle.net/10147/207212
Title:
Does a positive pretransplant crossmatch affect long-term outcome in liver transplantation?
Authors:
Al-Sibae, Mohamad R; Koffron, Alan J; Raofi, Vandad
Affiliation:
Division of Transplant and Hepatobiliary Surgery, William Beaumont, Hospital/Oakland University Medical School, Royal Oak, MI 48073, USA.
Citation:
Transplantation. 2011 Feb 15;91(3):261-2.
Journal:
Transplantation
Issue Date:
1-Feb-2012
URI:
http://hdl.handle.net/10147/207212
DOI:
10.1097/TP.0b013e318204758c
PubMed ID:
21107302
Abstract:
Despite the historical success of liver transplantation in the face of a positive lymphocytic crossmatch, increased incidence of acute cellular rejection and graft loss have been reported in this setting. Given the potential adverse effects of antirejection treatment, especially in hepatitis C virus-positive recipients, identification of predisposing factors could allow for better surveillance, avoidance of rejection, and potentially better graft outcomes.
Language:
eng
MeSH:
Graft Rejection/immunology/prevention & control; Hepatitis C/*surgery; *Histocompatibility Testing; Humans; Liver Transplantation/*immunology; Treatment Outcome
ISSN:
1534-6080 (Electronic); 0041-1337 (Linking)

Full metadata record

DC FieldValue Language
dc.contributor.authorAl-Sibae, Mohamad Ren_GB
dc.contributor.authorKoffron, Alan Jen_GB
dc.contributor.authorRaofi, Vandaden_GB
dc.date.accessioned2012-02-01T10:02:05Z-
dc.date.available2012-02-01T10:02:05Z-
dc.date.issued2012-02-01T10:02:05Z-
dc.identifier.citationTransplantation. 2011 Feb 15;91(3):261-2.en_GB
dc.identifier.issn1534-6080 (Electronic)en_GB
dc.identifier.issn0041-1337 (Linking)en_GB
dc.identifier.pmid21107302en_GB
dc.identifier.doi10.1097/TP.0b013e318204758cen_GB
dc.identifier.urihttp://hdl.handle.net/10147/207212-
dc.description.abstractDespite the historical success of liver transplantation in the face of a positive lymphocytic crossmatch, increased incidence of acute cellular rejection and graft loss have been reported in this setting. Given the potential adverse effects of antirejection treatment, especially in hepatitis C virus-positive recipients, identification of predisposing factors could allow for better surveillance, avoidance of rejection, and potentially better graft outcomes.en_GB
dc.language.isoengen_GB
dc.subject.meshGraft Rejection/immunology/prevention & controlen_GB
dc.subject.meshHepatitis C/*surgeryen_GB
dc.subject.mesh*Histocompatibility Testingen_GB
dc.subject.meshHumansen_GB
dc.subject.meshLiver Transplantation/*immunologyen_GB
dc.subject.meshTreatment Outcomeen_GB
dc.titleDoes a positive pretransplant crossmatch affect long-term outcome in liver transplantation?en_GB
dc.contributor.departmentDivision of Transplant and Hepatobiliary Surgery, William Beaumont, Hospital/Oakland University Medical School, Royal Oak, MI 48073, USA.en_GB
dc.identifier.journalTransplantationen_GB
dc.description.provinceLeinster-

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.